FDA is urged to increase regulatory oversight over tanning beds

12/14/2012 | Hill, The

The American Cancer Society is calling on federal officials to subject tanning beds to greater FDA oversight due to findings that the devices are associated with an increased risk of skin cancer. Makers of tanning beds contend there has been no proof of a link between their products and fatal cancers.

View Full Article in:

Hill, The

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC